Trevor James
On April 12, 1955, Thomas Francis, Jr. of the University of Michigan announced that the Salk polio vaccine was safe and effective. The announcement was made exactly ten years to the day after the death of President Franklin D. Roosevelt, who was believed to have died of polio. The news was met with jubilation across the United States, with church bells ringing, factory whistles blowing, and children being let out of school. The vaccine was the culmination of years of research by Dr. Jonas Salk and his team at the University of Pittsburgh, and it marked a significant turning point in the fight against polio, which had been the leading cause of death for American children in 1954.
| Characteristics | Values |
|---|---|
| Date of announcement | April 12, 1955 |
| Announced by | Thomas Francis, Jr. |
| Location of announcement | University of Michigan |
| Vaccine developer | Jonas Salk |
| University Salk was affiliated with | University of Pittsburgh |
| Number of children vaccinated in the trial | 1.8 million |
| Number of children vaccinated with Salk vaccine | 440,000 |
| Vaccine efficacy against PV1 | 60-70% |
| Vaccine efficacy against PV2 and PV3 | Over 90% |
| Vaccine efficacy against bulbar polio | 94% |
| Number of polio cases in the US in 1953 | 35,000 |
| Number of polio cases in the US in 1957 | 5,600 |
| Number of polio cases in the US in 1961 | 161 |
Explore related products
$2.99 $29.95
What You'll Learn
The announcement of the polio vaccine's safety and effectiveness
On April 12, 1955, Thomas Francis, Jr. of the University of Michigan, the monitor of the test results, announced the safety and effectiveness of the polio vaccine to an audience of scientists and reporters. This announcement was made exactly ten years to the day after the death of President Roosevelt, who had also suffered from polio. The vaccine was declared "safe, effective, and potent", and was possibly the most significant biomedical advance of the twentieth century.
The announcement led to spontaneous celebrations across the United States. Church bells rang out, factories paused production, and people flooded into the streets, hugging and kissing. Parents hugged their children with joy and relief. The New York Times described the report as "a medical classic". The news was carried worldwide by wire services and radio and television newscasts.
The vaccine was developed by Jonas Salk and his team at the University of Pittsburgh. It was the world's first successful polio vaccine, and it was made ready for its third and final field tests in 1954. This was the most elaborate program of its kind in history, involving 20,000 physicians and public health officers, 64,000 school personnel, and 220,000 volunteers. Over 1 million elementary school children were enrolled in the trials, making it the largest public health experiment in history.
The vaccine was administered to over 440,000 children in 44 states, three Canadian provinces, and Helsinki, Finland. It was found to be 80 to 90 percent effective, and by August 1955, some 4 million shots had been given. By 1956, cases of polio in the United States had dropped to 5,876, one-tenth of its 1952 peak. The United States has been polio-free since 1979, and today, 92.6 percent of children aged two and younger have been vaccinated against polio.
Booster Shots: Are You Fully Vaccinated Without Them?
You may want to see also
Explore related products
Spontaneous celebrations across the United States
On April 12, 1955, Thomas Francis, Jr. of the University of Michigan, announced the success of the polio vaccine, developed by Jonas Salk and his colleagues. This declaration was the result of the largest vaccine trial ever conducted at the time, involving nearly 2 million children. The vaccine was deemed "safe, effective, and potent," marking a pivotal moment in the history of medicine and public health.
The news of the vaccine's success sparked spontaneous celebrations across the United States. Church bells rang out, loudspeakers in department stores shared the announcement, and factories paused production to spread the joyous news to their workers. People flooded the streets, embracing each other with relief and happiness. Parents hugged their children, grateful for the newfound hope that this vaccine brought. It was a day that many compared to V-E Day or V-J Day, signifying victory over a formidable foe.
Businesses came to a standstill as the significance of the announcement sunk in. Dr. Salk became an overnight sensation, turning down a ticker-tape parade in New York City. President Dwight D. Eisenhower invited him to the White House and planned to bestow upon him a special presidential medal, recognizing him as "a benefactor of mankind." The Salk vaccine was readily accepted and celebrated, thanks in part to President Franklin D. Roosevelt's personal stake in eradicating polio, a disease that had left him paralyzed years earlier.
The success of the vaccine was not just a triumph of medicine but also a testament to the power of collaboration and global vaccination efforts. By choosing not to patent the vaccine, Salk ensured its widespread distribution, prioritizing public health over personal gain. This act of altruism, along with his subsequent founding of the Salk Institute for Biological Studies, further solidified his commitment to advancing science for the benefit of humanity.
The impact of the Salk vaccine extended beyond the immediate celebrations. Within a year of its release, 30 million inoculations were administered to children in the United States, leading to a nearly 50% drop in polio cases. By 1959, the vaccine had reached approximately 90 countries, and the United States has been polio-free since 1979. The success of the Salk vaccine serves as a powerful reminder of the life-saving potential of vaccines and the enduring importance of global collaboration in the name of public health.
mRNA Vaccines: Better Protection Without the Pathogen Risk
You may want to see also
Explore related products
The world's first successful polio vaccine
In the mid-20th century, the poliovirus was widespread and deadly, killing or paralysing over half a million people annually. The need for a cure was urgent, and in 1949, a breakthrough came when John Enders, Thomas Weller, and Frederick Robbins successfully cultivated the poliovirus in human tissue. This paved the way for the development of the first successful polio vaccine.
US physician Jonas Salk is credited with creating the first successful polio vaccine, an inactivated (killed) polio vaccine (IPV). Salk first tested his experimental vaccine on himself and his family in 1953 and later on 1.6 million children in Canada, Finland, and the USA in 1954. The results were announced on April 12, 1955, by Thomas Francis, Jr., who declared the vaccine "safe and effective." The announcement was met with spontaneous celebrations across the United States, with church bells ringing, factories observing moments of silence, and people embracing in the streets.
The development of Salk's polio vaccine involved a massive effort, including 20,000 physicians and public health officers, 64,000 school personnel, and 220,000 volunteers. The vaccine was administered to over 440,000 children in 44 states, three Canadian provinces, and Helsinki, Finland. By August 1955, about four million shots had been given, and by 1956, cases of polio in the United States had dropped significantly.
The success of Salk's vaccine led to the first modern mass inoculations, and it played a crucial role in the global effort to eradicate polio. The World Health Organization's South-East Asia region was certified polio-free in 2014, followed by the African region in 2020. As of July 2021, only two cases of wild poliovirus have been recorded globally, demonstrating the incredible impact of Salk's vaccine in saving lives and reducing the incidence of polio worldwide.
Unvaccinated Children: Health Risks and Social Impact
You may want to see also
Explore related products
$29
The Salk vaccine's effectiveness
The Salk vaccine, also known as the Salk polio vaccine or the inactivated poliovirus vaccine, was developed by Jonas Salk and his team at the University of Pittsburgh in 1952. It was the first effective polio vaccine, and its development was a rapid process, taking only six years from the initial lab discoveries to the 1954 field trials.
The vaccine's effectiveness was demonstrated in several trials. In one of the earliest trials, Salk inoculated his own children as part of the study. This trial showed a fourfold decrease in the incidence of paralytic polio in immunoglobulin recipients compared to gelatin controls, indicating that the vaccine could generate an antipolio antibody response, which would be protective against paralytic polio.
The 1954 field trials were the largest vaccine trials ever conducted at the time and involved more than a million elementary school children across the United States. These trials showed that the Salk vaccine was 60-70% effective against PV1 (poliovirus type 1), over 90% effective against PV2 and PV3, and 94% effective against the development of bulbar polio. Overall, the vaccine was found to be 80-90% effective in preventing paralytic poliomyelitis.
The success of the Salk vaccine was announced on April 12, 1955, by Thomas Francis, Jr., of the University of Michigan. The announcement led to spontaneous celebrations across the United States, with church bells ringing, factories observing moments of silence, and people flooding into the streets, hugging and kissing in joy and relief. The development of the Salk vaccine was a significant biomedical advance, and by 1956, cases of polio in the United States had dropped significantly, with the country being polio-free since 1979.
Vaccine Exemptions: Kids' Rights in Public Schools
You may want to see also
Explore related products
The immediate international rush to vaccinate
The announcement of the world's first safe and effective polio vaccine on April 12, 1955, by Thomas Francis, Jr., of the University of Michigan, triggered an immediate international rush to vaccinate. The vaccine was developed by Jonas Salk and his team at the University of Pittsburgh, and it was deemed a significant biomedical advance, especially since, in 1954, polio was the leading cause of death among American children.
The news of the vaccine's success was disseminated worldwide within minutes via wire services, radio, and television newscasts. The announcement led to spontaneous celebrations across the United States, with people embracing in the streets, kissing, and rejoicing. Church bells rang out, factories paused production, and synagogues and churches held prayer meetings. The vaccine's success was so impactful that one observer likened it to "a war had ended."
The international community swiftly recognized the importance of the Salk vaccine, and many countries embarked on polio immunization campaigns. Israel committed to the Salk vaccine just days before the final report was released. Soon after, Canada, Sweden, Denmark, Norway, West Germany, the Netherlands, Switzerland, and Belgium announced similar plans. The success of the Salk vaccine also prompted the development of the oral polio vaccine (OPV) by physician and microbiologist Albert Sabin, which came into commercial use in 1961.
The global effort to eradicate polio continued in subsequent years. In 1979, Rotary International initiated a project to immunize 6 million children in the Philippines. The World Health Assembly passed a resolution to eradicate polio in 1988, and the Global Polio Eradication Initiative (GPEI) was launched the same year. With the support of WHO, vaccine production was expanded globally, with notable contributions from countries like India and Indonesia. These collective efforts, combined with international initiatives and assistance, have played a crucial role in the ongoing battle against polio worldwide.
Blue Cross Blue Shield Illinois: Understanding Your Vaccine Coverage
You may want to see also
Frequently asked questions
Yes, church bells rang out across America to announce the Salk vaccine.
The Salk vaccine is the world's first successful polio vaccine, declared "safe, effective, and potent".
The public reaction to the announcement was one of celebration and relief. People flooded into the streets, kissing and embracing.
